These include B-rafV600E mutations and high-degree promoter methylations in CpG islands of sporadic tumors (HROC24P, HROC87X); and a K-ras mutation but CIMPneg in the HNPCC-associated HROC113P. Here, KRAS is linked to hereditary nonpolyposis colon cancer.